GSK3B and hepatoblastoma: On the other hand, in lithium-treated cells, the nuclear complex GSK3β/p53 is disrupted, conferring chemoresistance to apoptosis in hepatoblastoma cells (HepG2) through GSK3β inhibition and repression of Cd95 expression [107].